Northeast Bank (NBN)

Ligand Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	413.62	242.06	197.81	169.48	1,008
Investment Securities	22.7	53.84	57.02	57.08	58.82
Mortgage-Backed Securities	-	2.16	3.16	4.63	8.15
Total Investments	22.7	55.99	60.17	61.71	66.97
Gross Loans	3,756	2,748	2,521	1,305	1,041
Allowance for Loan Losses	-47.93	-26.71	-7.3	-5.03	-7.31
Other Adjustments to Gross Loans	-	-1.01	-0.37	-0.6	-0.33
Net Loans	3,708	2,720	2,513	1,300	1,033
Property, Plant & Equipment	24.7	27.14	27.74	9.61	11.27
Loans Held for Sale	33.77	14.51	-	-	-
Accrued Interest Receivable	16.9	15.16	6.64	-	-
Other Receivables	-	1.6	-	-	-
Restricted Cash	-	0.1	0.1	2.6	2.6
Long-Term Deferred Tax Assets	-	13.71	13.26	8.59	9.58
Other Real Estate Owned & Foreclosed	0.56	-	-	-	1.64
Other Long-Term Assets	43.06	26.24	26.52	29.33	39.93
Total Assets	4,279	3,132	2,870	1,583	2,174
Interest Bearing Deposits	3,216	2,086	1,719	939.19	882.24
Institutional Deposits	-	107.1	74.1	19.5	7.7
Non-Interest Bearing Deposits	159.27	146.73	143.74	329.01	972.5
Total Deposits	3,376	2,339	1,937	1,288	1,862
Current Portion of Long-Term Debt	-	-	311	15	30.05
Current Portion of Leases	-	2.43	-	-	-
Long-Term Debt	-	-	-	0.22	2.03
Federal Home Loan Bank Debt, Long-Term	320.19	345.19	251.62	-	-
Long-Term Leases	19.04	17.82	21.92	4.45	6.06
Other Long-Term Liabilities	69.95	50.66	51.54	27.07	41.44
Total Liabilities	3,785	2,756	2,573	1,334	1,942
Common Stock	8.53	8.13	7.67	7.44	8.15
Additional Paid-In Capital	98.73	64.76	42.84	38.75	64.42
Retained Earnings	387.04	303.93	246.87	202.98	161.13
Comprehensive Income & Other	-0	-0.18	-0.72	-0.85	-1.31
Shareholders' Equity	494.29	376.63	296.66	248.32	232.39
Total Liabilities & Equity	4,279	3,132	2,870	1,583	2,174
Total Debt	339.24	365.44	584.53	19.67	38.15
Net Cash (Debt)	74.38	-123.38	-386.72	149.81	969.75
Net Cash Growth	-	-	-	-84.55%	975.18%
Net Cash Per Share	8.99	-16.07	-52.16	18.96	115.99
Filing Date Shares Outstanding	8.53	8.22	7.8	7.54	8.18
Total Common Shares Outstanding	8.53	8.13	7.67	7.44	8.15
Book Value Per Share	57.98	46.34	38.69	33.37	28.51
Tangible Book Value	494.29	376.63	296.66	248.32	232.39
Tangible Book Value Per Share	57.98	46.34	38.69	33.37	28.51

Updated May 8, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.

SEC Filings: 10-K · 10-Q